Detalhe da pesquisa
1.
Replication study of plasma proteins relating to Alzheimer's pathology.
Alzheimers Dement
; 17(9): 1452-1464, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792144
2.
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
Alzheimers Dement
; 15(5): 644-654, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30853464
3.
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
Alzheimers Dement
; 15(11): 1478-1488, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31495601
4.
Inflammatory biomarkers in Alzheimer's disease plasma.
Alzheimers Dement
; 15(6): 776-787, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31047856
5.
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
Alzheimers Dement
; 15(6): 817-827, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31078433
6.
ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset.
J Alzheimers Dis
; 79(1): 423-431, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33285634
7.
Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort.
Biomedicines
; 9(11)2021 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34829839
8.
Differences in cohort study data affect external validation of artificial intelligence models for predictive diagnostics of dementia - lessons for translation into clinical practice.
EPMA J
; 11(3): 367-376, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32843907
9.
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
J Alzheimers Dis
; 74(1): 213-225, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31985466
10.
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.
J Alzheimers Dis
; 77(3): 1353-1368, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32831200
11.
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort.
Alzheimers Dement (N Y)
; 5: 933-938, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31890857
12.
A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.
J Alzheimers Dis
; 62(3): 1181-1198, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29562526
13.
Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result.
Front Aging Neurosci
; 10: 409, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30618716
14.
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology.
Alzheimers Res Ther
; 9(1): 31, 2017 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28441961
15.
Blood-Based Biomarker Candidates of Cerebral Amyloid Using PiB PET in Non-Demented Elderly.
J Alzheimers Dis
; 52(2): 561-72, 2016 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27031486
16.
Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology.
Front Neurol
; 6: 236, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26635716
17.
Blood protein predictors of brain amyloid for enrichment in clinical trials?
Alzheimers Dement (Amst)
; 1(1): 48-60, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27239491
18.
Evaluation of a calibrated (18)F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment.
J Nucl Med
; 52(8): 1218-26, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21764801